ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1549

Prevalence of Co-Morbidities and Evaluation of Their Monitoring in Korean Patients with RA: Comparison with the Results of an International, Cross-Sectional Study (COMORA)

In Ah Choi1, Sung-Hwan Park2, Hoon-Suk Cha3, Won Park4, Hyun Ah Kim5, Dae-Hyun Yoo6, Han Joo Baek7, SeungGeun Lee8, Yoon Jong Lee9, Yong Bum Park10, Seung-Cheol Shim11, Ihsane Hmamouchi12 and Yeong Wook Song13, 1Rheumatology, Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, Seoul, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 4Division of Rheumatology, Department of Internal Medicine, Inha University Hospital, Incheon, South Korea, 5Division of Rheumatology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, South Korea, 6Division of Rheumatology, Department of Internal Medicine, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 7Rheumatology, Gachon University Gil Medical Center, Incheon, South Korea, 8Division of Rheumatology, Department of Internal Medicine, Pusan Nationl University Hospital, Busan, South Korea, 9Division of rheumatology Seoul National University Bundang Hospital, Seongnam, South Korea, 10Division of Rheumatology, Department of Internal Medicine, Yoesei University Severance Hospital, Seoul, South Korea, 11Division of Rheumatology, Department of Internal Medicine, Eulji University Hospital, Daejeon, South Korea, 12El Ayachi Hospital, Rabat, Morocco, 13Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Comorbidity and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid Arthritis (RA) patients are at increased risk of developing co-morbid conditions. We designed this study to evaluate the prevalence of comorbidities and their monitoring in Korean RA patients compared with the patients from other countries.

Methods: We analyzed the demographics, disease characteristics, comorbidities and their monitoring states of 1050 RA patients from 11 Korean centers and compared with those of 3520 patients from 16 other countries using COMORA database.

Results:

The prevalence of obese patients was significantly lower and married patients was higher in Korean patients (p<0.0001, both). Disease duration was shorter, uses of prednisolone and NSAIDs were more frequent and the use of biologics was lower in Korean patients (p<0.0001, all). The prevalence of cardiovascular (CV) event was not significantly different between two groups. The prevalence of basocellular skin cancer was significantly lower in Korean patients (p<0.0001).

The proportion of current smoker, patients who have a family history of CV disease, hyperlipidemia and patients with Framingham score >20% were significantly lower, although the prevalence of diabetes was higher in Korean patients (p<0.0001, all).

Annual evaluation of CV risk was less frequently performed in Korean (p=0.0011) although the use of antiplatelet agent was more frequent (p=0.0004). Prostatic and skin cancer monitoring were less frequently performed (p<0.0001) but lung and breast cancer monitoring were more frequently performed (p=0.048 and p<0.0001). Vitamin D supplement was less frequently used (p<0.0001).

When we analyzed the association of GI disease with medication, the risk of GI ulcer was increase with prednisolone (Odds ratio 1.68, 95% CI 1.34-2.09) and NSAIDs (odds ratio 1.44, 95% CI 1.16-1.79) in patients from other countries. The usage of NSAID was protective for the development of colon cancer in RA patients of Korea (odds ratio 0.09, 95% CI 0.01-0.86) and other countries (odds ratio 0.3, 95% CI 0.12-0.75). The usage of biologic agents increased the risk of lymphoma in countries other than Korea (odds ratio 19.08, 95% CI 2.51-145.27).

Conclusion: There are differences in the prevalence of co-morbidities and monitoring states of the risk factors between patients in Korea and the other countries. The prevalence of CV morbidity was similar between two groups although the prevalence of CV risk factors is significantly low in Korean, suggesting more attention to yearly CV risk monitoring is needed. The usage of NSAID was protective for the development of colon cancer in RA patients of Korea and other countries.


Disclosure: I. A. Choi, None; S. H. Park, None; H. S. Cha, None; W. Park, None; H. A. Kim, None; D. H. Yoo, None; H. J. Baek, None; S. Lee, None; Y. J. Lee, None; Y. B. Park, None; S. C. Shim, None; I. Hmamouchi, None; Y. W. Song, None.

To cite this abstract in AMA style:

Choi IA, Park SH, Cha HS, Park W, Kim HA, Yoo DH, Baek HJ, Lee S, Lee YJ, Park YB, Shim SC, Hmamouchi I, Song YW. Prevalence of Co-Morbidities and Evaluation of Their Monitoring in Korean Patients with RA: Comparison with the Results of an International, Cross-Sectional Study (COMORA) [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/prevalence-of-co-morbidities-and-evaluation-of-their-monitoring-in-korean-patients-with-ra-comparison-with-the-results-of-an-international-cross-sectional-study-comora/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-co-morbidities-and-evaluation-of-their-monitoring-in-korean-patients-with-ra-comparison-with-the-results-of-an-international-cross-sectional-study-comora/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology